Industry News
Biotechnology Industry News

Chutes & Ladders—A new Spark, in CEO form, at Roche’s gene therapy biotech
Chutes & Ladders—A new Spark, in CEO form, at Roche's gene therapy biotech klahucik Thu, 02/24/2022 - 11:45
Takeda, Arch back hC Bioscience with $24M for transfer RNAs, following Flagship into the field
Takeda, Arch back hC Bioscience with $24M for transfer RNAs, following Flagship into the field klahucik Thu, 02/24/2022 - 11:01
Orphazyme goes soul searching as EU advisers add 2nd rejection for rare disease drug
Orphazyme goes soul searching as EU advisers add 2nd rejection for rare disease drug klahucik Thu, 02/24/2022 - 09:28
Merck cuts ties to Moderna’s early-phase KRAS vaccine, leaving mRNA specialist to mull next steps
Merck cuts ties to Moderna's early-phase KRAS vaccine, leaving mRNA specialist to mull next steps ntaylor Thu, 02/24/2022 - 08:52
Amicus’ gene therapy SPAC merger folds, turning pipeline and R&D into target of $400M in cuts
Amicus' gene therapy SPAC merger folds, turning pipeline and R&D into target of $400M in cuts ntaylor Thu, 02/24/2022 - 07:51
Mnemo lures Bayer oncology business chief as new CEO to lead CAR-T work
Mnemo lures Bayer oncology business chief as new CEO to lead CAR-T work mbayer Wed, 02/23/2022 - 10:31
Kodiak’s Eylea rival hits ‘major disappointment’ with failure in first of 6 phase 3 studies
Kodiak's Eylea rival hits 'major disappointment' with failure in first of 6 phase 3 studies klahucik Wed, 02/23/2022 - 09:04
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators ntaylor Wed, 02/23/2022 - 07:39
Stability woes torpedo Marinus’ phase 3 seizure timeline, combining with COVID-19 to cause one-year delay
Stability woes torpedo Marinus' phase 3 seizure timeline, combining with COVID-19 to cause one-year delay ntaylor Wed, 02/23/2022 - 05:04
Roche’s gene therapy unit finds a new Spark as co-founding CEO makes way for new leader
Roche's gene therapy unit finds a new Spark as co-founding CEO makes way for new leader klahucik Tue, 02/22/2022 - 23:45
‘Better than Abecma’: Slimmed-down 2seventy charts own course after bluebird split
'Better than Abecma': Slimmed-down 2seventy charts own course after bluebird split mbayer Tue, 02/22/2022 - 18:34
Poseida taps former Novartis VP as president of gene therapy
Poseida taps former Novartis VP as president of gene therapy mbayer Tue, 02/22/2022 - 15:09
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up klahucik Tue, 02/22/2022 - 11:44
The Importance of the Patient in Advancing Care in Rare Diseases
The Importance of the Patient in Advancing Care in Rare Diseases mwen Tue, 02/22/2022 - 10:41
Adagio CEO resigns with no explanation and the biotech plans COVID-19 antibody analysis this quarter
Adagio CEO resigns with no explanation and the biotech plans COVID-19 antibody analysis this quarter klahucik Tue, 02/22/2022 - 10:09
Building off Prevail buy, Lilly to construct $700 million Boston research hub in gene therapy blitz
Building off Prevail buy, Lilly to construct $700 million Boston research hub in gene therapy blitz mbayer Tue, 02/22/2022 - 09:41
Building off Prevail buy, Lilly to construct $700M Boston research hub in gene therapy blitz
Building off Prevail buy, Lilly to construct $700M Boston research hub in gene therapy blitz mbayer Tue, 02/22/2022 - 09:41
Moderna’s RSV shot sails on to phase 3, tightening Big Pharma battle royale
Moderna's RSV shot sails on to phase 3, tightening Big Pharma battle royale aarmstrong Tue, 02/22/2022 - 09:20
Takeda’s gene therapy ambitions rise another $2B in 4-program Code Bio pact
Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact klahucik Tue, 02/22/2022 - 08:36
BioNTech jumps into PRAME game, paying Medigene $29M for preclinical T-cell therapy program
BioNTech jumps into PRAME game, paying Medigene $29M for preclinical T-cell therapy program ntaylor Tue, 02/22/2022 - 05:57

